Four NYU Wagner Alumni Named 2025 City & State Nonprofit Trailblazers

Alexandros Hatzakis, Marissa Mack, Michelle Morazan, Kimberleigh Smith

In City & State’s 2025 Nonprofit Trailblazers list, four NYU Wagner alumni were recognized for their extraordinary contributions to the community. 

Alexandros Hatzakis (MPA-PNP 2013), chief operating officer and associate executive director, FPWA

In his role at FPWA, Hatzakis spearheads the organization’s strategic planning in its efforts to eliminate poverty and further racial justice. Hatzakis has helped the organization advocate for higher wages for human services workers, for increased statewide minimum wage, and for the establishment of a racial equity office. 

Marissa Mack (EMPA 2018), managing director, marketing and business development, Webster Bank

Mack’s role blends banking with civic engagement, developing tactics involving foundation support and strategic partnerships designed to support nonprofits. A native of Harlem, Mack also serves on the committee for the Imagine Awards, which honor excellence in New York City nonprofits. 

Michelle Morazán (MPA 1999), vice president of policy and strategy development, Somos Community Care

Morazán has dedicated her career to advocating for a more equitable health care system. In her current role at Somos Community Care, a network centered around value-based care, she’s developing strategy to increase access to housing, food, and transit by connecting primary care with local organizations. 

Kimberleigh Smith (MPA 1999), executive vice president of public policy and advocacy, Callen-Lorde Community Health Center

Smith’s career in HIV and LGTBQ+ health justice spans more than two decades. Now at Callen-Lorde—where she started as a patient—Smith spearheads efforts to improve access to affirming care for BIPOC, transgender, and nonbinary communities and to long-acting HIV prevention. In her policy work, Smith was also a part of an effort to pass legislation that banned commercial insurance plans from requiring prior authorization for treatment of HIV or AIDS.